{"title":"Development and Validation of an Optimized and Horizontal Imaged Capillary Isoelectric Focusing Method for mAbs Charge Heterogeneity Analysis.","authors":"Ghizzani Virginia, Gonnella Federico, Gaggioli Andrea, Carocci Alberto, Luciani Francesca, Ascione Alessandro","doi":"10.1016/j.ejps.2025.107297","DOIUrl":null,"url":null,"abstract":"<p><p>Charge heterogeneity is widely recognized as a Critical Quality Attribute for mAbs, and imaged capillary isoelectric focusing has become the high-throughput gold standard technique for both manufacturers and regulatory agencies. Considering the exponential spread of mAbs across a wide range of medical applications, the current lack of analytical procedure harmonization renders the feasibility of charge variants evaluation increasingly challenging, particularly in the context of large-scale control activities by supervisory authorities. This issue is highlighted by relevant EDQM's activities within the Biological Standardisation Programme, as well as by a recent publication in Ph. Eur. of a special general chapter on mAbs charge variant analysis by (i)ciEF. To satisfactorily address this urgent demand, the present article describes the development and validation of a mAbs cross-applicable icIEF method fully aligned with the Ph. Eur. Concept. The optimized method provides a further improvement in terms of accuracy, precision and linearity with respect to the general method published in Ph. Eur., as validated according ICH Q2(R2) requirements and elevating the isoelectric point as a valuable identity parameter for mAbs. These results represent a significant advance in the standardization of icIEF technique, thereby streamlining its utilisation in routine quality control activities and reinforcing its relevance in the anti-counterfeiting domain.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107297"},"PeriodicalIF":4.7000,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejps.2025.107297","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Charge heterogeneity is widely recognized as a Critical Quality Attribute for mAbs, and imaged capillary isoelectric focusing has become the high-throughput gold standard technique for both manufacturers and regulatory agencies. Considering the exponential spread of mAbs across a wide range of medical applications, the current lack of analytical procedure harmonization renders the feasibility of charge variants evaluation increasingly challenging, particularly in the context of large-scale control activities by supervisory authorities. This issue is highlighted by relevant EDQM's activities within the Biological Standardisation Programme, as well as by a recent publication in Ph. Eur. of a special general chapter on mAbs charge variant analysis by (i)ciEF. To satisfactorily address this urgent demand, the present article describes the development and validation of a mAbs cross-applicable icIEF method fully aligned with the Ph. Eur. Concept. The optimized method provides a further improvement in terms of accuracy, precision and linearity with respect to the general method published in Ph. Eur., as validated according ICH Q2(R2) requirements and elevating the isoelectric point as a valuable identity parameter for mAbs. These results represent a significant advance in the standardization of icIEF technique, thereby streamlining its utilisation in routine quality control activities and reinforcing its relevance in the anti-counterfeiting domain.
期刊介绍:
The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development.
More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making.
Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.